Filter by
Clear filters
Messepiazza 1.
FROM Oct 08th 2024 TO Oct 10th 2024
VISION 2024
Visit Exosens at VISION 2024 - Booth 8C26, Hall 8 in Stuttgart. VISION 2024 is the world’s leading exhibition for machine vision technologies and system integrators.
Jul 24th 2024
Strong first half 2024 revenue with continuing growth Momentum
Exosens (Euronext FR001400Q9V2 – EXENS), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology components, achieved consolidated revenue of €186.9 million for the first half 2024.
Jul 08th 2024
Exosens announces the implementation of a liquidity contract with Kepler Cheuvreux
EXOSENS S.A. (Euronext Paris: FR001400Q9V2) announces today the implementation of a liquidity agreement with Kepler Cheuvreux to enhance the liquidity of EXOSENS shares admitted to trading on Euronext Paris....
Jun 28th 2024
SVOM Mission launches successfully
Photonis contributes cutting-edge technology to svom mission, advancing our understanding of gamma-ray bursts
Moscone Center, San Francisco, CA.
FROM Jul 09th 2024 TO Jul 11th 2024
SEMICON WEST 2024
Visit Exosens at SEMICON West 2024 from July 9 to 11 in San Francisco.
Jun 14th 2024
Exosens announces presence at eurosatory 2024
17th-21st june 2024 - Eurosatory, parc des expositions paris-nord villepinte - hall 6 stand k51
Jun 12th 2024
Full exercise of the over-allotment option for €52.5 million
Exosens S.A. (Compartment A, ISIN code FR001400Q9V2, ticker symbol « EXENS »), a high-tech company focused on providing mission and performance-critical amplification, detection...
Jun 07th 2024
Exosens announces the success of its Initial Public Offering on Euronext Paris
In light of strong demand from investors in the placement, Exosens today announces that it increases the size of the Offering in the context of its initial public offering to 350 million euros...
Jun 05th 2024
Exosens increases the size of the offering in the context of its Initial Public Offering
In light of strong demand from investors in the placement, Exosens today announces that it increases the size of the Offering in the context of its initial public offering to 350 million euros...
Jun 03rd 2024
Exosens launches its Initial Public Offering on Euronext Paris
Exosens launches today its initial public offering on Euronext Paris through a private placement. The main purpose of the IPO is to enable the Group to reduce its debt in order to increase its financial flexibility...
May 31st 2024
El-Mul Detection Technology for TOFMS
Collaboration between El-Mul technology, MSC and Acqiris contributing to innovative high dynamic range TOFMS technology
May 30th 2024
Revolutionary ion detection solutions for mass spectrometry instruments
Exosens to unveil revolutionary ion detection solutions for mass spectrometry instruments based on Photonis and El-Mul technologies
May 23rd 2024
Exosens announces the approval of its Registration Document
Exosens announces the approval of its registration document by the French Autorité des marchés financiers (“AMF”) and takes a first step towards its ipo on Euronext Paris
May 16th 2024
Photonis and newcleo have signed their first purchase order
Photonis, a leading brand of Exosens, and newcleo have signed their first purchase order to explore the deployment of the nuclear instrumentation detectors in the reactor core
Apr 09th 2024
Exosens Adds Innovative Photon Counting System, LINCam
Exosens Adds Innovative Photon Counting System, LINCam, to its Portfolio of Single Photon Sensitive Detectors
Feb 06th 2024
Occar renew their trust in Photonis' expertise
Photonis shall deliver 40,000 image intensifier tubes to boost military night vision in Germany and Belgium
KINTEX Exhibition Center Ⅱ.
FROM Sep 25th 2024 TO Sep 28th 2024
DX KOREA 2024
Visit Exosens at DX KOREA 2024 from September 25 to 28 in KINTEX Exhibition Center Ⅱ, Korea